Non-nucleoside reverse transcriptase inhibitors
Dolutegravir; Rilpivirine
Composition
- Active ingredients
- DOLUTEGRAVIR 50MG/25MG; RILPIVIRINE
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA213120.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Dolutegravir; Rilpivirine
- Active substance
- dolutegravir
- Drug class
- Non-nucleoside reverse transcriptase inhibitors, Integrase inhibitors, Antivirals for treatment of HIV infections, combinations
- Group
- Antivirals
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Lupin LTD
- Status
- Tentative approval